Insider Transactions
| Date | Name | Title | Filing | Type | Shares Traded | Price Range | Total Held |
|---|---|---|---|---|---|---|---|
| Jul 14, 2020 | SVP Global Operations and R&D | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 7,540 | -- | 23,962 | |
| Jul 17, 2019 | EVP and CFO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 7,660 | -- | 28,391 | |
| Jul 21, 2021 | SVP/GM, VIT | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 7,721 | -- | 7,721 | |
| Jul 20, 2022 | SVP and General Counsel | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 7,925 | -- | 7,925 | |
| Jul 22, 2015 | EVP and CFO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 7,958 | -- | 7,958 | |
| Jul 20, 2022 | EVP and CFO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 7,961 | -- | 88,498 | |
| Jul 25, 2014 | SVP - Global Franchise Leader | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 7,965 | -- | 7,965 | |
| Jul 20, 2022 | SVP/GM, Vascular Access | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 7,974 | -- | 7,974 | |
| Jul 26, 2017 | Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 7,976 | -- | 7,976 | |
| Jul 26, 2017 | Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 7,976 | -- | 55,576 |
For recent transactions, including derivative transactions, see our Section 16 SEC filings page.